Molecular mediators of hepatic steatosis and liver injury
Jeffrey D. Browning(Unknown), Jay D. Horton(Center for Human Genetics)
Cited by 1,765
Related Papers
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
|Journal of Clinical Investigation|2002|4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.
|Journal of Clinical Investigation|1998|707
Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver
|Journal of Biological Chemistry|2004|501